Media Contact

Larissa Doucette

The United States House of Representatives Committee on Energy and Commerce is examining the facts related to the meningitis outbreak that has been linked to intrathecal methylprednisolone injections compounded by NECC and has requested additional documentation from FDA. The committee has reviewed an FDA warning letter sent to the company in December 2006 and other related information provided by FDA, the Massachusetts Board of Registration in Pharmacy, and NECC. The committee has now sent a letter requesting FDA to provide a full history of the agency’s oversight of the NECC “to better understand its knowledge of the operations and whether subsequent inspections were conducted after the initial warning letter,” as indicated in a press release from the Committee.